Chargement en cours...
First-line endocrine treatment of breast cancer: aromatase inhibitor or antioestrogen?
Until recently, endocrine therapy for breast cancer was relatively simple. If the tumour expressed hormone receptors, regardless of stage and age, tamoxifen was indicated. While this largely remains the case for premenopausal women, clinical trials in postmenopausal women have broadened our choice t...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Nature Publishing Group
2004
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2395329/ https://ncbi.nlm.nih.gov/pubmed/14710200 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6601508 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|